Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Temporary Equity And Stockholders' (Deficiency) Equity

v3.8.0.1
Consolidated Statement of Changes in Temporary Equity And Stockholders' (Deficiency) Equity - USD ($)
Series B Convertible Redeemable Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Balance beginning at Dec. 31, 2015 $ 388,793 $ (14,070) $ 69,933,147 $ (9,591,274) $ (57,589,428) $ 3,127,168
Balance beginning, shares at Dec. 31, 2015 38,879,333 4,411        
Common stock issued for cash, net of issuance costs of $4,500 $ 31,468 7,066,394 $ 7,097,862
Common stock issued for cash, net of issuance costs of $4,500, shares 3,146,875       1,608,200
Common stock issued for price modification $ 4,708 936,822 $ 941,530
Common stock issued for price modification, shares 470,771        
Exchange of 12.5% notes for common stock $ 377 75,056 75,433
Exchange of 12.5% notes for common stock, shares 37,700        
Stock-based compensation: Common stock issued under 401(k) profit sharing plan $ 307 76,443 76,750
Stock-based compensation: Common stock issued under 401(k) profit sharing plan, shares 30,700        
Options and warrants 1,131,056 1,131,056
Vesting of restricted stock $ 3,500 793,722 797,222
Vesting of restricted stock, share 350,000        
Warrant modification expense 89,549 89,549
Common stock issued in satisfaction of deferred revenue            
Net loss (10,042,141) (10,042,141)
Other comprehensive loss (867,968) (867,968)
Balance ending at Dec. 31, 2016 $ 429,153 $ (14,070) 80,102,189 (10,459,242) (67,631,569) 2,426,461
Balance ending, shares at Dec. 31, 2016 42,915,379 4,411        
Common stock issued for cash, net of issuance costs of $4,500 $ 225 40,275 40,500
Common stock issued for cash, net of issuance costs of $4,500, shares 22,500        
Common stock issued for price modification            
Stock-based compensation: Common stock issued under 401(k) profit sharing plan $ 678 73,190 73,868
Stock-based compensation: Common stock issued under 401(k) profit sharing plan, shares 67,770        
Options and warrants 623,907 623,907
Vesting of restricted stock            
Series B preferred stock issued for cash $ 7,759,500
Series B preferred stock issued for cash, shares 775,931        
Common stock issued in satisfaction of deferred revenue $ 622 123,917 124,539
Common stock issued in satisfaction of deferred revenue, shares 62,270        
Exchange of 8% notes for Series B preferred stock $ 1,267,324
Exchange of 8% notes for Series B preferred stock, shares 126,739        
Dividends paid (60,515) (60,515)
True-up to transfer agent's records $ (4) 4
True-up to transfer agent's records, shares (373)          
Net loss (7,912,512) (7,912,512)
Other comprehensive loss (336,568) (336,568)
Balance ending at Dec. 31, 2017 $ 9,026,824 $ 430,674 $ (14,070) $ 80,902,967 $ (10,795,810) $ (75,544,081) $ (5,020,320)
Balance ending, shares at Dec. 31, 2017 902,670 43,067,546 4,411